cyc 202 has been researched along with transforming growth factor beta in 5 studies
| Studies (cyc 202) | Trials (cyc 202) | Recent Studies (post-2010) (cyc 202) | Studies (transforming growth factor beta) | Trials (transforming growth factor beta) | Recent Studies (post-2010) (transforming growth factor beta) |
|---|---|---|---|---|---|
| 979 | 7 | 393 | 49,119 | 560 | 17,610 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, KS; Eom, YW; Ha, MJ; Kang, Y; Kim, SJ; Rhee, H; Yoon, JW | 1 |
| Bang, YJ; Hong, SH; Jong, HS; Kim, NK; Kim, SG; Kim, SJ; Kim, SN | 1 |
| Feghali-Bostwick, CA; Robinson, AR; Steinman, RA | 1 |
| He, X; Liu, W; Wang, S; Zhang, Y; Zhao, H; Zhao, X; Zhou, Y | 1 |
| Sakai, M; Yoshimura, R | 1 |
5 other study(ies) available for cyc 202 and transforming growth factor beta
| Article | Year |
|---|---|
Cdc2 and Cdk2 kinase activated by transforming growth factor-beta1 trigger apoptosis through the phosphorylation of retinoblastoma protein in FaO hepatoma cells.
Topics: Animals; Apoptosis; CDC2 Protein Kinase; CDC2-CDC28 Kinases; Cell Cycle; Cell Death; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinases; Enzyme Activation; Enzyme Inhibitors; Kinetin; Liver Neoplasms, Experimental; Phosphorylation; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-bcl-2; Purines; Rats; Retinoblastoma Protein; RNA, Messenger; Roscovitine; Transforming Growth Factor beta; Tumor Cells, Cultured | 1999 |
Caspase-mediated Cdk2 activation is a critical step to execute transforming growth factor-beta1-induced apoptosis in human gastric cancer cells.
Topics: Annexin A5; Apoptosis; Blotting, Western; Bromodeoxyuridine; Caspase 3; Caspases; CDC2-CDC28 Kinases; Cell Cycle; Cell Cycle Proteins; Cell Division; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; Cyclin-Dependent Kinases; Cyclins; Enzyme Activation; Enzyme Inhibitors; Gene Expression Regulation, Neoplastic; Humans; In Situ Nick-End Labeling; Kinetin; Microtubule-Associated Proteins; Phosphorylation; Precipitin Tests; Protein Serine-Threonine Kinases; Purines; Retinoblastoma Protein; RNA, Messenger; Roscovitine; Stomach Neoplasms; Transforming Growth Factor beta; Tumor Cells, Cultured; Tumor Suppressor Proteins | 2001 |
Antifibrotic effects of roscovitine in normal and scleroderma fibroblasts.
Topics: Animals; Collagen; Connective Tissue Growth Factor; Fibroblasts; Fibronectins; Fibrosis; Humans; Interleukin-6; Mice; NIH 3T3 Cells; Phosphorylation; Purines; Roscovitine; Scleroderma, Systemic; Signal Transduction; STAT3 Transcription Factor; Transcription, Genetic; Transforming Growth Factor beta; Up-Regulation | 2012 |
Roscovitine attenuates renal interstitial fibrosis in diabetic mice through the TGF-β1/p38 MAPK pathway.
Topics: Animals; Cell Line; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Dose-Response Relationship, Drug; Epithelial-Mesenchymal Transition; Fibrosis; Humans; Kidney; Kidney Function Tests; Male; Mice, Inbred Strains; p38 Mitogen-Activated Protein Kinases; Roscovitine; Signal Transduction; Streptozocin; Transforming Growth Factor beta | 2019 |
Mechanotransduction-Targeting Drugs Attenuate Stiffness-Induced Hepatic Stellate Cell Activation in Vitro.
Topics: Actins; Adenosine Triphosphate; Animals; Benzamides; Cells, Cultured; Colchicine; Collagen Type I; Hepatic Stellate Cells; Imidazoles; Integrins; Male; Mechanotransduction, Cellular; Paclitaxel; Piperazines; Pyrazines; Quinoxalines; Rats, Sprague-Dawley; Roscovitine; Sulfonamides; Transforming Growth Factor beta; Tubulin Modulators | 2021 |